4//SEC Filing
SPECTOR STEVEN W 4
Accession 0001209191-19-053339
CIK 0001080709other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 8:22 PM ET
Size
10.1 KB
Accession
0001209191-19-053339
Insider Transaction Report
Form 4
SPECTOR STEVEN W
SVP, General Counsel & Sec
Transactions
- Exercise/Conversion
Common Stock
2019-10-14+6,300→ 15,990 total - Tax Payment
Common Stock
2019-10-14$47.32/sh−3,123$147,780→ 12,867 total - Exercise/Conversion
Performance Restricted Stock Unit
2019-10-14−6,300→ 18,900 totalExp: 2022-01-03→ Common Stock (6,300 underlying)
Footnotes (3)
- [F1]On January 4, 2019, the Reporting Person was granted 12,600 target Performance Restricted Stock Units ("PRSUs"). The PRSUs represented a contingent right to receive a number of shares of Arena's common stock equal to 50%, 100%, or 200% of the target PRSU amount. Such common shares vest, if at all, upon the closing price of Arena's common stock (the "Closing Price") reaching certain thresholds during the three-year performance period from January 4, 2019, through January 3, 2022 (the "Performance Period") and satisfaction of a subsequent continuing service requirement. On October 14, 2019, 6,300 of the shares subject to the PRSUs vested (50% of the target amount). Up to an additional 18,900 shares remain issuable pursuant to the PRSUs (200% of the target amount, less the 50% already vested) if all currently outstanding Closing Price targets are met during the Performance Period and subsequent continuing service requirements are met.
- [F2]Represents the number of shares withheld by, and surrendered to, Arena relating to tax withholding in connection with the issuance of shares under the PRSUs.
- [F3]The amount reported in Column 7 of Table II represents the common shares that vested on October 14, 2019. Under the PRSUs, the Reporting Person has a contingent right to receive up to 18,900 additional common shares if all currently outstanding Closing Price targets are met during the Performance Period and subsequent continuing service requirements are met.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001170362
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 8:22 PM ET
- Size
- 10.1 KB